Pramipexole marketed for Parkinson's disease.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D052160:Benzothiazoles; D017277:Drug Approval; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D013844:Thiazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D013844:Thiazoles; D000077487:Pramipexole